Kirsten Grønbæk

Kirsten Grønbæk

Clinical Professor

Member of:

  • Internal Medicine: Haematology


  1. 2020
  2. Published

    KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study

    Ferrero, S., Rossi, D., Rinaldi, A., Bruscaggin, A., Spina, V., Eskelund, C. W., Evangelista, A., Moia, R., Kwee, I., Dahl, C., Di Rocco, A., Stefoni, V., Diop, F., Favini, C., Ghione, P., Mahmoud, A. M., Schipani, M., Kolstad, A., Barbero, D., Novero, D. & 13 others, Paulli, M., Zamò, A., Jerkeman, M., Gomez Da Silva, M., Santoro, A., Molinari, A., Ferreri, A., Grønbæk, Kirsten, Piccin, A., Cortelazzo, S., Bertoni, F., Ladetto, M. & Gaidano, G., 2020, In: Haematologica. 105, 6, p. 1604-1612

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    The diagnostic and prognostic role of flow cytometry in idiopathic and clonal cytopenia of undetermined significance (ICUS/CCUS): A single-center analysis of 79 patients

    Dimopoulos, K., Hansen, O. K., Sjö, Lene Dissing, Saft, L., Schjødt, I. M., Hansen, Jakob Werner & Grønbæk, Kirsten, 2020, In: Cytometry. Part B: Clinical Cytometry. 98, 3, p. 250-258

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samples

    Jørgensen, S., Paulsen, I. W., Hansen, Jakob Werner, Tholstrup, Dorte Maegaard, Hother, C., Sørensen, E., Petersen, M. S., Nielsen, K. R., Rostgaard, K., Larsen, M. A. H., Brown, Peter de Nully, Ralfkiær, E., Homburg, K. M., Hjalgrim, Henrik, Erikstrup, C., Ullum, H., Troelsen, J., Grønbæk, Kirsten & Pedersen, Ole Birger Vesterager, 2020, In: Scientific Reports. 10, 1, 9637.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma

    Rodrigues, J. M., Hassan, M., Freiburghaus, C., Eskelund, C. W., Geisler, C., Räty, R., Kolstad, A., Sundström, C., Glimelius, I., Grønbæk, Kirsten, Kwiecinska, A., Porwit, A., Jerkeman, M. & Ek, S., 2020, In: British Journal of Haematology. 191, 5, p. 796-805

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. 2019
  7. Published

    Increased neonatal level of arginase 2 in cases of childhood acute lymphoblastic leukemia implicates immunosuppression in the etiology

    Nielsen, A. B., Zhou, M., de Smith, A. J., Wang, R., McCoy, L., Hansen, H., Morimoto, L., Grønbæk, Kirsten, Johansen, Christoffer, Kogan, S. C., Metayer, C., Bracci, P. M., Ma, X. & Wiemels, J. L., Nov 2019, In: Haematologica. 104, 11, p. e514-e516 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes

    Gillberg, Linn, mxz703, mxz703, Nasif, A., Ohtani, H., Madaj, Z., Hansen, Jakob Werner, Rapin, N., Mogensen, J. B., Liu, M., Dufva, I. H., Lykkesfeldt, Jens, Hajkova, P., Jones, P. A. & Grønbæk, Kirsten, 17 Oct 2019, In: Clinical Epigenetics. 11, 1, p. 143-153 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients

    Urup, T., Gillberg, Linn, Kaastrup, K., Lu, M. S., Michaelsen, Signe Regner, Larsen, V. A., Christensen, I. J., Broholm, H., Lassen, Ulrik Niels, Grønbæk, Kirsten & Poulsen, H. S., 2019, In: Neuro-Oncology. 21, Supplement 6, p. vi149

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  10. Published

    Epigenetic therapy in hematological cancers

    Dimopoulos, K. & Grønbæk, Kirsten, 2019, In: A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 127, 5, p. 316-328 13 p.

    Research output: Contribution to journalReviewResearchpeer-review

  11. Published

    Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma

    Dimopoulos, K., Fibiger Munch-Petersen, H., Winther Eskelund, C., Sjö, Lene Dissing, Ralfkiær, E., Gimsing, P. & Grønbæk, Kirsten, 2019, In: Leukemia and Lymphoma. 60, 1, p. 180-188

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up

    Baliakas, P., Tesi, B., Wartiovaara-kautto, U., Stray-pedersen, A., Friis, L. S., Dybedal, I., Hovland, R., Jahnukainen, K., Raaschou-Jensen, K., Ljungman, P., Rustad, C. F., Lautrup, C. K., Kilpivaara, O., Kittang, A. O., Grønbæk, Kirsten, Cammenga, J., Hellström-lindberg, E. & Andersen, M. K., 2019, In: HemaSphere. 3, 6, p. 1-10 e321.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...5 6 7 8 9 10 11 12 ...17 Next

ID: 37722667